— Know what they know.
Not Investment Advice
Also trades as: H02.SI (SES) · $vol 3M · HAWPF (OTC) · $vol 0M

HAWPY OTC

Haw Par Corporation Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +5.3% 1Y: +5.3% 3Y: +101.7% 5Y: +123.3%
$53.50
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 61 · $3.0B mcap · 35M float · 0.0000% daily turnover · Short 80% of daily vol

Income Trends

Revenue
$226M -7.6% ▼
5Y CAGR: +15.3%
Gross Profit
$127M -5.5% ▼
5Y CAGR: +21.0%
Operating Income
$66M +3.4% ▲
5Y CAGR: +36.5%
Net Income
$261M +14.4% ▲
5Y CAGR: +16.9%
EPS (Diluted)
$4.72 +14.6% ▲
5Y CAGR: +16.9%
EBITDA
$72M -71.6% ▼
5Y CAGR: +28.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$141M$182M$232M$245M$226M
YoY Growth+27.2%+29.0%+27.4%+5.5%-7.6%
Cost of Revenue$68M$84M$97M$111M$100M
Gross Profit$74M$99M$135M$134M$127M
Gross Margin52.2%54.1%58.1%54.8%56.0%
R&D Expenses$0$0$0$0$0
SG&A Expenses$49M$55M$71M$70M$61M
Operating Expenses$49M$55M$71M$134M$61M
Operating Income$25M$43M$64M$64M$66M
Operating Margin17.5%23.8%27.6%26.1%29.2%
Interest Expense$0$0$2M$2M$1M
Income Before Tax$116M$159M$229M$246M$277M
Tax Expense$6M$11M$13M$18M$16M
Net Income$110M$148M$217M$228M$261M
Net Margin78.0%81.5%93.3%93.2%115.4%
EPS (Diluted)$2.00$2.68$3.92$4.12$4.72
EBITDA$31M$49M$70M$254M$72M
Shares Outstanding55M55M55M55M55M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms